This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
A little more than half a year after establishing a healthcare affordability lab, Yale University is out with freshly detailed policy prescriptions for cutting costs without compromising care.
The agency said the move comes after a May 2026 audit of Medicaid outcomes found that states are motivated more by a desire to check boxes than to ensure patients are healthy. Once completed, the new framework will ideally align financial incentives with care outcomes.
Patient engagement expert John Deutsch says consumers are already used to “frictionless experiences” when it comes time to catch a ride or buy a coffee. Can AI bring healthcare up to speed?
Of surveyed and interviewed U.S. physicians who showed significant six-month improvement in follow-up vs. baseline wellness checks, 47% attributed the gain to active personal changes. Not far behind were those who credited active work-related changes—40% of the field.
Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.
Cardiologists were asked to develop a care strategy for CAD patients before and after using an FDA-approved AI tool to evaluate CT results. In two out of three cases, the AI influenced cardiologists to modify their original plan.
The past four years have witnessed major advancements in medical science’s drive to unravel the complexities of the human immune system. We have the COVID-19 pandemic to thank for much of the progress.
The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more space for operators to guide and maneuver the catheter during procedures.
Members of Congress are now asking the FDA to investigate a parent's claim that her 14-year-old son was treated with an experimental heart valve without proper consent. The valve eventually failed and had to be replaced. The hospital has said its heart team did nothing wrong.
“Most health systems rely on a financial cost-containment model to inform staffing decisions. Clinicians understand the patient populations and needs over time, yet they are currently excluded from most staffing decisions,” the authors write.